Back to search results

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer · Malignant Neoplasm of Prostate · Secondary Malignant Neoplasm of Prostate

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Angela Y Jia, MD, PhD) · Angela.Jia@UHhospitals.org · 216-844-3262

  • Carbone Cancer Center University of Wisconsin-Madison, Madison, Wisconsin, United States

    Contact: Study coordinator (Christos Kyriakopoulos, MD) · ckyriako@medicine.wisc.edu · 608-263-0786
    Contact: Principal Investigator (Christos Kyriakopoulos, MD)
Study leads

  • Angela Y Jia, MD, PhD

    Principal Investigator

    University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

  • Daniel E Spratt, MD

    Study Chair

    University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)